WordNet

(genetics) a segment of DNA that is involved in producing a polypeptide chain; it can include regions preceding and following the coding DNA as well as introns between the exons; it is considered a unit of heredity; "genes were formerly called factors" (同)cistron, factor
informal term for information; "give me the gen on your new line of computers"

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 急性前骨髄球性白血病の分子生物学 molecular biology of acute promyelocytic leukemia
2. 急性骨髄性白血病における細胞遺伝学 cytogenetics in acute myeloid leukemia
3. 急性骨髄性白血病の分子遺伝学 molecular genetics of acute myeloid leukemia
4. 成人における急性前骨髄球性白血病の初期治療 initial treatment of acute promyelocytic leukemia in adults
5. 急性前骨髄球性白血病の臨床症状、病理学的特徴、および診断 clinical manifestations pathologic features and diagnosis of acute promyelocytic leukemia in adults

Characterization of wheat-Secale africanum chromosome 5Ra derivatives carrying Secale specific genes for grain hardness.

Li G1, Gao D1, La S1, Wang H1, Li J1, He W1, Yang E2, Yang Z3.
Planta.Planta.2016 Feb 16. [Epub ahead of print]
MAIN CONCLUSION: New wheat- Secale africanum chromosome 5R a substitution and translocation lines were developed and identified by fluorescence in situ hybridization and molecular markers, and chromosome 5R a specific genes responsible for grain hardness were isolated. The wild species, Secale afric
PMID 26883668

Saleem M, Yusoff NM.
Hematology (Amsterdam, Netherlands).Hematology.2016 Feb 12. [Epub ahead of print]
Objectives The new World Health Organization's (WHO) classification of haematopoietic and lymphoid tissue neoplasms incorporating the recurrent fusion genes as the defining criteria for different haematopoietic malignant phenotypes is reviewed. The recurrent fusion genes incorporated in the new WHO'
PMID 26871368

Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.

Shigeto S1, Matsuda K2, Yamaguchi A3, Sueki A1, Uehara M3, Sugano M1, Uehara T1, Honda T1.
Clinica chimica acta; international journal of clinical chemistry.Clin Chim Acta.2016 Jan 30;453:38-41. doi: 10.1016/j.cca.2015.12.001. Epub 2015 Dec 2.
BACKGROUND: Acute promyelocytic leukemia (APL) with the PML-RARA fusion gene can be effectively cured using molecular-targeted therapies, which require both detection and quantification of the PML-RARA fusion gene. Here, we developed a rapid assay for identifying and measuring the PML-RARA fusion ge
PMID 26656442